Methyl 2,3,4-Trimethoxybenzoate

Methyl 2,3,4-Trimethoxybenzoate

SCHEMBL1434191

COC(=O)c1ccc(OC)c(OC)c1OC

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.57
▸ KDM4E B2RXH2 5/20 0.56
▸ POLB P06746 2/20 0.56
▸ PKM P14618 1/20 0.55
▸ MAPT P10636 2/20 0.55
▸ TDP1 Q9NUW8 1/20 0.55
▸ MEN1 O00255 3/20 0.54
▸ KMT2A Q03164 3/20 0.54
▸ USP2 O75604 1/20 0.51
▸ HSD17B10 Q99714 1/20 0.51
▸ PDE4D Q08499 2/20 0.51
▸ NPC1 O15118 2/20 0.48
▸ RAB9A P51151 2/20 0.48
▸ CASP3 P42574 1/20 0.48
▸ SENP7 Q9BQF6 1/20 0.48
▸ SENP6 Q9GZR1 1/20 0.48
▸ TUBB1 Q9H4B7 3/20 0.48
▸ GAA P10253 1/20 0.48
▸ CYP3A4 P08684 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6852879 0.89 CA1 (0.52) ALDH1A1KDM4EPOLBMAPTTDP1
SCHEMBL8526786 0.88 MAPT (0.55) ALDH1A1PKMMAPTTDP1MEN1
SCHEMBL6945911 0.85 KDM4E (0.46) ALDH1A1KDM4EPOLBPKMMAPT
SCHEMBL23051546 0.85 MAPT (0.51) ALDH1A1KDM4EPOLBPKMMAPT
SCHEMBL30466421 0.85 LMNA (0.55) ALDH1A1KDM4EPOLBPKMMAPT
SCHEMBL24136599 0.85 LMNA (0.55) ALDH1A1KDM4EPOLBPKMMAPT
SCHEMBL16513023 0.85 HTT (0.50) ALDH1A1KDM4EPOLBPKMMAPT
SCHEMBL1434290 0.85 MAPT (0.71) ALDH1A1KDM4EPOLBMAPTTDP1
SCHEMBL885177 0.84 PDE4D (0.57) ALDH1A1KDM4EPOLBPKMMAPT
SCHEMBL9726919 0.83 MAPT (0.58) ALDH1A1PKMMAPTTDP1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102942529-B 4-(4-substituted piperazine)-5,6,7-trialkoxy quinazoline type compound as well as preparation method and application of 4-(4-substituted piperazine)-5,6,7-trialkoxy quinazoline type compound UNIV GUIZHOU 2015-06-24 — — CN claimed
CN-118782903-A Non-aqueous electrolyte, lithium ion battery and diaphragm-free lithium ion battery 重庆太蓝新能源有限公司 2024-10-15 — — CN disclosed
CN-110603431-B Temperature detection material, temperature detection ink using same, temperature indicator, and article management system 株式会社日立产机系统 2021-06-15 — — CN disclosed
CN-110603431-A Temperature detection material, temperature detection ink using same, temperature indicator, and article management system 株式会社日立产机系统 2019-12-20 — — CN disclosed
CN-105037279-B 4 N substituted quinazolines analog derivatives of the structure containing pentadienone and preparation and application 贵州大学 2017-11-03 — — CN disclosed
US-20170052449-A1 CHEMICALLY AMPLIFIED RESIST MATERIAL, PATTERN-FORMING METHOD, COMPOUND, AND PRODUCTION METHOD OF COMPOUND OSAKA UNIVERSITY (JP) 2017-02-23 — — US disclosed
US-20170052449-A1 CHEMICALLY AMPLIFIED RESIST MATERIAL, PATTERN-FORMING METHOD, COMPOUND, AND PRODUCTION METHOD OF COMPOUND OSAKA UNIVERSITY (JP) 2017-02-23 — — US disclosed
CN-105037279-A 4-N substituted quinazoline derivants adopting pentadienone structure and preparation and application of 4-N substituted quinazoline derivants UNIV GUIZHOU 2015-11-11 — — CN disclosed
CN-102942529-B 4-(4-substituted piperazine)-5,6,7-trialkoxy quinazoline type compound as well as preparation method and application of 4-(4-substituted piperazine)-5,6,7-trialkoxy quinazoline type compound UNIV GUIZHOU 2015-06-24 — — CN disclosed
CN-101611005-B Substituted acetophenones useful as PDE4 inhibitors LEO PHARMA AS 2013-11-06 — — CN disclosed
US-20100035908-A1 SUBSTITUTED ACETOPHENONES USEFUL AS PDE4 INHIBITORS LEO PHARMA (DK) 2010-02-11 — — US disclosed
US-20100035908-A1 SUBSTITUTED ACETOPHENONES USEFUL AS PDE4 INHIBITORS LEO PHARMA (DK) 2010-02-11 — — US disclosed
CN-101611005-A Be used as the acetophenones of the replacement of PDE4 inhibitor LEO PHARMA AS (DK) 2009-12-23 — — CN disclosed
EP-2125736-A1 SUBSTITUTED ACETOPHENONES USEFUL AS PDE4 INHIBITORS Leo Pharma A/S (DK) 2009-12-02 — — EP disclosed
WO-2008077404-A1 SUBSTITUTED ACETOPHENONES USEFUL AS PDE4 INHIBITORS LEO PHARMA A/S (DK) 2008-07-03 — — WO disclosed
WO-2008077404-A1 SUBSTITUTED ACETOPHENONES USEFUL AS PDE4 INHIBITORS LEO PHARMA A/S (DK) 2008-07-03 — — WO disclosed
US-6716987-B1 PHOSPHODIESTERASE IV INHIBITORS KYOWA HAKKO KOGYO CO., LTD. (JP) 2004-04-06 — — US disclosed
US-6514996-B2 Derivatives of benzofuran or benzodioxole KYOWA HAKKO KOGYO CO., LTD. (JP) 2003-02-04 — — US disclosed
US-20020128290-A1 DERIVATIVES OF BENZOFURAN OR BENZODIOXOLE KYOWA HAKKO KOGYO CO., LTD. (JP) 2002-09-12 — — US disclosed
EP-0943613-A1 OXYGENIC HETEROCYCLIC COMPOUNDS KYOWA HAKKO KOGYO KABUSHIKI KAISHA (JP) 1999-09-22 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020128290-A1 DERIVATIVES OF BENZOFURAN OR BENZODIOXOLE CBR1, CBR3, CYC1 ALDH1A1 323/4885KDM4E 3975/4885POLB 1985/4885
US-20100035908-A1 SUBSTITUTED ACETOPHENONES USEFUL AS PDE4 INHIBITORS PDE4A, PDE4B, PDE3B ALDH1A1 457/4885KDM4E 772/4885POLB 1669/4885
US-20170052449-A1 CHEMICALLY AMPLIFIED RESIST MATERIAL, PATTERN-FORMING METHOD, COMPOUND, AND PRODUCTION METHOD OF COMPOUND RER1, POLR1A, FEM1B ALDH1A1 1044/4885KDM4E 3338/4885POLB 68/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback